Travere Therapeutics to Present at Upcoming Investor Conferences

SAN DIEGO, March 28, 2023 (GLOBE NEWSWIRE) — Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced that Company management will participate in the following upcoming conferences: Guggenheim Healthcare Talks | Genomic Medicines and Rare Disease Days, Tuesday, April 4, 2023, at 3:55 p.m. ET. BofA Securities 2023 Health Care Conference, Wednesday, May 10, 2023, at 3:40 p.m. PT.

View Full Press Release
Travere Therapeutics Announces Interim Analysis from the Phase 3 PROTECT Study of FILSPARI™ (Sparsentan) in IgA Nephropathy Published in The Lancet and Presented at World Congress of Nephrology 2023